Model for End-Stage Liver Disease Exceptions in the Context of the French Model for End-Stage Liver Disease Score-Based Liver Allocation System

被引:67
作者
Francoz, Claire [1 ,8 ]
Belghiti, Jacques [2 ]
Castaing, Denis [3 ]
Chazouilleres, Olivier [4 ]
Duclos-Vallee, Jean-Charles [3 ]
Duvoux, Christophe [5 ]
Lerut, Jan [6 ]
Le Treut, Yves-Patrice [7 ]
Moreau, Richard [8 ]
Mandot, Ameet [1 ]
Pageaux, Georges [9 ]
Samuel, Didier [3 ]
Thabut, Dominique [10 ]
Valla, Dominique [1 ,8 ]
Durand, Francois [1 ,8 ]
机构
[1] Beaujon Hosp, Dept Hepatol, F-92110 Clichy, France
[2] Beaujon Hosp, Dept Hepatobiliary & Pancreat Surg, F-92110 Clichy, France
[3] Hop Paul Brousse, Hepatobiliary Ctr, Villejuif, France
[4] St Antoine Hosp, Dept Hepatol, Paris, France
[5] Henri Mondor Hosp, Dept Hepatol, Creteil, France
[6] St Luc Univ Hosp, Dept Abdominal & Transplantat Surg, Brussels, Belgium
[7] Hosp Concept, Dept Digest Surg, Marseille, France
[8] Natl Inst Hlth & Med Res, U773, Bichat Beaujon Ctr Biomed Res CRB3, Paris, France
[9] St Eloi Hosp, Dept Hepatol, Montpellier, France
[10] Hop La Pitie Salpetriere, Dept Hepatol, Paris, France
关键词
HEREDITARY HEMORRHAGIC TELANGIECTASIA; INTRAHEPATIC PORTOSYSTEMIC SHUNT; HUMAN-IMMUNODEFICIENCY-VIRUS; QUALITY-OF-LIFE; POLYTETRAFLUOROETHYLENE-COVERED STENT; NODULAR REGENERATIVE HYPERPLASIA; BUDD-CHIARI-SYNDROME; HEPATITIS-B-VIRUS; POLYCYSTIC LIVER; PORTOPULMONARY HYPERTENSION;
D O I
10.1002/lt.22363
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Model for End-Stage Liver Disease (MELD) score-based allocation systems have been adopted by most countries in Europe and North America. Indeed, the MELD score is a robust marker of early mortality for patients with cirrhosis. Except for extreme values, high pretransplant MELD scores do not significantly affect posttransplant survival. The MELD score can be used to optimize the allocation of allografts according to a sickest first policy. Most often, patients with small hepatocellular carcinomas (HCCs) and low MELD scores receive extra points, which allow them appropriate access to transplantation comparable to the access of patients with advanced cirrhosis and high MELD scores. In addition to patients with advanced cirrhosis and HCC, patients with a number of relatively uncommon conditions have low MELD scores and a poor prognosis in the short term without transplantation but derive excellent benefits from transplantation. These conditions, which correspond to the so-called MELD score exceptions, justify the allocation of a specific score for appropriate access to transplantation. Here we report the conclusions of the French consensus meeting. The goals of this meeting were (1) to identify which conditions merit MELD score exceptions, (2) to list the criteria needed for defining each of these conditions, and (3) to define a reasonable time interval for organ allocation for each MELD exception in the general context of organ shortages. MELD exceptions were discussed in an attempt to reconcile the concepts of transparency, equity, justice, and utility. Liver Transpl 17: 1137-1151, 2011. (C) 2011 AASLD.
引用
收藏
页码:1137 / 1151
页数:15
相关论文
共 123 条
[1]   Normalised intrinsic mortality risk in liver transplantation: European Liver Transplant Registry study [J].
Adam, R ;
Cailliez, V ;
Majno, P ;
Karam, V ;
McMaster, P ;
Calne, RY ;
O'Grady, J ;
Pichlmayr, R ;
Neuhaus, P ;
Otte, JB ;
Hoeckerstedt, K ;
Bismuth, H .
LANCET, 2000, 356 (9230) :621-627
[2]   The course and prognostic factors of familial amyloid polyneuropathy after liver transplantation [J].
Adams, D ;
Samuel, D ;
Goulon-Goeau, C ;
Nakazato, M ;
Costa, PMP ;
Feray, C ;
Planté, V ;
Ducot, B ;
Ichai, P ;
Lacroix, C ;
Metral, S ;
Bismuth, H ;
Said, G .
BRAIN, 2000, 123 :1495-1504
[3]   Proposal of progression model for intrahepatic cholangiocarcinoma: Clinicopathologic differences between hilar type and peripheral type [J].
Aishima, Shinichi ;
Kuroda, Yousuke ;
Nishihara, Yunosuke ;
Iguchi, Tomohiro ;
Taguchi, Kenichi ;
Taketomi, Akinobu ;
Maehara, Yoshihiko ;
Tsuneyoshi, Masazumi .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2007, 31 (07) :1059-1067
[4]   Non-absorbable disaccharides for hepatic encephalopathy: systematic review of randomised trials [J].
Als-Nielsen, B ;
Gluud, LL ;
Gluud, C .
BMJ-BRITISH MEDICAL JOURNAL, 2004, 328 (7447) :1046-1050
[5]  
Als-Nielsen B., 2004, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003047.pub2, DOI 10.1002/14651858.CD003047.PUB2]
[6]   Epidemiology of viral hepatitis and HIV co-infection [J].
Alter, MJ .
JOURNAL OF HEPATOLOGY, 2006, 44 :S6-S9
[7]   Influence of hepatic encephalopathy on health-related quality of life in patients with cirrhosis [J].
Arguedas, MR ;
DeLawrence, TG ;
McGuire, BM .
DIGESTIVE DISEASES AND SCIENCES, 2003, 48 (08) :1622-1626
[8]   Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis [J].
Arroyo, V ;
Gines, P ;
Gerbes, AL ;
Dudley, FJ ;
Gentilini, P ;
Laffi, G ;
Reynolds, TB ;
RingLarsen, H ;
Scholmerich, J .
HEPATOLOGY, 1996, 23 (01) :164-176
[9]   The impact of treatment of portopulmonary hypertension on survival following liver transplantation [J].
Ashfaq, M. ;
Chinnakotla, S. ;
Rogers, L. ;
Ausloos, K. ;
Saadeh, S. ;
Klintmalm, G. B. ;
Ramsay, M. ;
Davis, G. L. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 (05) :1258-1264
[10]   Extended Liver Resection for Polycystic Liver Disease Can Challenge Liver Transplantation [J].
Aussilhou, Beatrice ;
Doufle, Ghislaine ;
Hubert, Catherine ;
Francoz, Claire ;
Paugam, Catherine ;
Paradis, Valerie ;
Farges, Olivier ;
Vilgrain, Valerie ;
Durand, Francois ;
Belghiti, Jacques .
ANNALS OF SURGERY, 2010, 252 (05) :735-741